Lipoid proteinosis. A biochemical and ultrastructural investigation of two new cases

British Journal of Dermatology

Volumn 141, Issue 2, 1999, Pages 326-331

  Navarro, C ^a   Fachal, C ^a   Rodriguez C ^a   Padro L ^b   Dominguez C ^b  

^a HOSPITAL DO MEIXOEIRO   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Biochemistry; Ceramide; Collagen production; Complex lipids; Lipoid proteinosis; Metabolic defect; Ultrastructural study

Indexed keywords

ALPHA LEVO FUCOSIDASE; ALPHA MANNOSIDASE; BETA GALACTOSIDASE; BETA GLUCOSIDASE; BETA GLUCURONIDASE; BETA N ACETYLHEXOSAMINIDASE; CERAMIDE; CEREBROSIDE SULFATASE; LIPID; N ACETYL BETA GLUCOSAMINIDASE; N ACETYLGALACTOSAMINE 4 SULFATASE;

ADULT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CELL ULTRASTRUCTURE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FEMALE; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPOID PROTEINOSIS; MALE; PRIORITY JOURNAL; SKIN BIOPSY; TISSUE DISTRIBUTION;

ADULT; COLLAGEN; FEMALE; HUMANS; LIPID METABOLISM; LIPOID PROTEINOSIS OF URBACH AND WIETHE; LYSOSOMAL STORAGE DISEASES; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED;

EID: 0032790784     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.02986.x     Document Type: Article

References (28)

1. Urbach K, Wiethe C, Lipoidosis cutis et mucosae. Virchows Arch Pathol Anal 1929; 273: 286-319.
2. Pierard G, Cauwenberge D, Budo J, Lapiere CH. A clinicopathologic study of six cases of lipoid proteinosis. Am J Dematopathol 1988; 10: 300-5.
3. Caccamo D, Jaen A, Talenta M et al. Lipoid prognosis of the small bowel. Arch Pathal Lab Med 1994; 118: 572-4.
4. Caplan RM, Visceral involvement in lipoid proteinosis. Arch Dermatol 1967; 95: 149-55.
5. Moy LS, Moy RL, Matsuoka LY et al. Lipoid prognosis: ultra-structural and biochemical studies. J Am Acad Dermatol 1987; 16: 1193-201.
6. Paster L, Emsley RA. Lipoid profeinosis presenting with neuropsychiatric manifestations. J Neurol Neurosurg Psychiatry 1985; 16: 1193-2001.
7. Williamson BK, Island R. Histology of lipoid proteinosis. JAMA 1994; 272: 564-5.
8. Fleischmajer R, Krieg T, Dziadek M et al. Ultrastructure and composition of connective tissue in hyalinosis cutis et mucosae skin. J Invest Dermatal 1984; 82: 252-8.
9. Bauer EA, Santa Cruz P, Eisen AZ. Lipoid proteinosis: in vivo and in vitro evidence for a lysosomal storage disease. J Invest Dermatol 1981; 76: 119-25.
10. Newton JA, Rasbridge S, Temple A et al. Lipoid proteinosis: new immunopathological observations. Clin Exp Dermatol 1991; 19: 350-4.
11. Muda AO, Paradisi M, Angelo C et al. Lipoid proteinosis; clinical, histologic and ultrastructural investigations. Cutis 1995; 56: 220-4.
12. Zappatini-Tommasi L, Dumontel C, Guibaud P, Girod C. Farber disease: an ultrastructural study. Report of a case and review of the literature. Virchows Arch A Pathol Anat 1992; 420: 281-90.
13. Navarro C, Domínguez C, Costa M, Ortega JJ. Bone marrow transplant in a case of mucopolysaccharidosis I Scheie phenotype: skin ultrastructure before and after transplantation. Acta Neuropathol 1991; 82: 33-8.
14. Sancho S, Navarro C, Fernández JM et al. Skin biopsy findings in glycogenosis III: clinical, biochemical and electrophysiological correlations. Ann Neurol 1990; 27: 480-6.
15. Fratantoni JC, Hall CW, Neufeld EF. The defect in Hurler's syndromes; fault of degradation of mucopolysaccharides, Proc Natl Acad Sci USA 1968; 60: 699-706.
16. Lowry OH, Rosebrough NJ, Farr LA, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 153: 265-75.
17. Holtz K, Über Gehirn- und Augeurcrain derungen bei Hyalinosis cutis et mucosac (lipoidproteinose) mit Autopsiebefund, Arch Klin Exp Derm 1962; 214: 289-306.
18. Olsen DR, Chu ML, Uitto J. Expression of basement membrane zone genes coding for type IV procollagen and laminin by human skin fibroblast In vitro: elevated (TV) collagen mRNA levels In lipold proteinosis. I Invest Dermatol 1988; 90: 734-8.
19. Harper J, Duance V, Sims T. Light N. Lipoid proteinosis: an inherited disorder of collagen metabolism? Br J Dermatol 1985; 113: 145-51.
20. Navarro C, Soncho S. Valor de la biopsia de piel y conjuntiva en el diagnóstico de las enfermedades lisosomales de depósito. Patología 1988; 21: 1-6.
21. Ceuterick C, Martin JJ. Electron microscopic features of skin in neurometabolic disorders. J Neurol Sci 1992; 112: 15-29.
22. Prassad A, Kaye EM, Alroy J. Electron microscopic examination of skin biopsy as a cost effective tool in the diagnosis of lysosomal storage diseases. J Child Neurol 1996; 11: 1-8.
23. Sipe TC, O'Brien JS. Ultrastructure of skin biopsy specimens in lysosomal storage diseases: common sources of errors in diagnosis. Clin Genet 1979; 15: 118-25.
24. Moser HW. Ceramide deficiency: Farber lipogranulomatosis. In: The Metabolic and Molecular Bases of Inherited Diseases (Scriver CR, Beaudet AL, Sly WS, Valle D, eds), 7th edn. New York: McGraw-Hill, 1995: 2589-99.
25. van Hoof F, Hers HG (eds), Farber's disease. In: Lysosomes and Storage Diseases. New York; Academic Press, 1973; 559-62.
26. Schmockel C, Hohlfed M. A specific ultrastructural marker for disseminated lipogranulomatosis (Farber). Arch Dermatol Res 1979; 266: 187-96.
27. Abenoza P, Sibley RK. Farber's disease: a fine structural study. Ultrastruct Pathol 1987; 11: 397-403.
28. Walter S, Goebel HH. Ultrastructure pathology of dermal axons and Schwann cells in lysosomal diseases. Acta Neuropathol 1988; 76: 489-95.